NEW YORK (GenomeWeb News) – Bioinformatics firm GenoSplice Technology and Institut Curie's Curie-Cancer today said they are collaborating in the area of cancer genomics.

GenoSplice will have access to several Curie-Cancer technology platforms and be included in Institut Curie research programs. In addition to contributing to the development of new oncology products, the collaboration will result in a better understanding of complex diseases through genome mapping, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.